61
Participants
Start Date
July 31, 2015
Primary Completion Date
October 13, 2017
Study Completion Date
June 5, 2018
FP-02.2 Vaccine
Synthetic Peptide Hepatitis B Vaccine
Placebo
Placebo
IC31® Adjuvant
IC31® Adjuvant
Keimyung University Dongsan Medical Center, Daegu
Kyungpook National University Hospital, Daegu
Pusan National University Busan Hospital, Busan
Pusan National University Yangsan Hospital, Yangsan
Korea University Guro Hospital, Seoul
Seoul National University Hospital, Seoul
Yonsei University Health System Severance Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul St. Mary's Hospital, Seoul
SMG-SNU Boramae Medical Center, Seoul
University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham
University Hospitals Bristol, Bristol
Barts and The London School of Medicine and Dentistry, Blizzard Institiue, London
King's College Hospital, London
Royal Free Hospital, London
St. George's Hospital and Medical School, London
Imperial College London - St Mary's Campus, London
Pennine Acute Hospitals, Manchester
Bradford Teaching Hospitals, Bradford Royal Infirmary, North Yorks
Queen's Medical Centre, Nottingham Hospital, Nottingham
Lead Sponsor
Altimmune, Inc.
INDUSTRY